Radiculopathy associated with disc herniation.
Goupille
P
P
Mulleman
D
D
Valat
J-P
JP
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D000069285:Infliximab; D007403:Intervertebral Disc / Q000276:immunology; D007405:Intervertebral Disc Displacement / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D023421:Models, Animal; D011843:Radiculopathy / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000502:physiology
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept